In real-time records of 3 million attacks, eletriptan emerged as the most effective among 25 of the most commonly used acute migraine medications across seven pharmacologic classes.
Numerous medications have shown efficacy for acute treatment of migraine. However, studies directly comparing these medications remain sparse, were small, and measured only single-attack efficacy. In this study, researchers leveraged real-world health data from 278,006 patients via a smartphone headache diary application, analyzing 3,119,517 migraine attacks to produce a comprehensive direct comparison of 25 of the most commonly used acute migraine medications across seven pharmacologic classes. Medications included acetaminophen (paracetamol), nonsteroidal anti-inflammatory drugs (NSAIDs), combined acetaminophen/acetylsalicylic acid/caffeine, antiemetics, opioids, ergots, and triptans. Among 34% of patients with available data, 90.7% were …
Reviewing Authors
DisclosuresConsultant/Advisory BoardAeon Biopharma; Allergan/Abbvie; CoolTech LLC; Dr Reddys; Eli Lilly and Company, Epalex; Lundbeck; Novartis; Pfizer; Praxis; Sanofi; Teva Pharmaceuticals and Tremeau; Gerson Lehrman Group; Guidepoint; Massachusetts Medical Society; Vector Metric; UptoDate
RoyaltiesOxford University Press; Wolters Kluwer
Grant/Research SupportCelgene
Leadership Positions in Professional SocietiesAmerican Headache Society (Immediate Past President)
OtherPatent on magnetic stimulation for headache assigned to eNeura without fee
DisclosuresConsultant/Advisory BoardAeon Biopharma; Allergan/Abbvie; CoolTech LLC; Dr Reddys; Eli Lilly and Company, Epalex; Lundbeck; Novartis; Pfizer; Praxis; Sanofi; Teva Pharmaceuticals and Tremeau; Gerson Lehrman Group; Guidepoint; Massachusetts Medical Society; Vector Metric; UptoDate
RoyaltiesOxford University Press; Wolters Kluwer
Grant/Research SupportCelgene
Leadership Positions in Professional SocietiesAmerican Headache Society (Immediate Past President)
OtherPatent on magnetic stimulation for headache assigned to eNeura without fee